Kratom Research Institute

Research · 2026-01-01

Lab Study Finds "Kratom Extract" Products Are Synthetically Altered, Not Botanical Kratom

Source: Journal of AOAC International

Why it matters

Consumers and regulators have struggled to distinguish traditional kratom leaf from highly concentrated 7-OH products sold under the "kratom extract" label. This peer-reviewed study provides chemical proof that marketed 7-OH products are synthetic derivatives, not botanical kratom — a distinction critical for appropriate regulation and consumer safety.

The big picture

As kratom use grew in the United States over the past decade, a new category of products emerged: concentrated forms of 7-hydroxymitragynine (7-HMG) sold as "kratom extracts." Unlike traditional kratom leaf consumed for centuries in Southeast Asia, these products contain unusually high 7-HMG levels only achievable through chemical synthesis. The study's findings directly supported subsequent FDA and DEA actions in 2026 to restrict concentrated 7-OH products while leaving botanical kratom in a separate regulatory category.

Key findings

What they say

The authors concluded: "There is an urgent need to differentiate kratom, which has been safely consumed for centuries, from 7-hydroxymitragynine, which may pose a significant risk to public health."

Bottom line

Chemical analysis proves that products sold as "kratom extracts" are synthetically produced 7-OH compounds — not botanical kratom — making their labeling unlawful and their regulatory treatment distinct from traditional kratom leaf.